Chargement en cours...
Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels
Synthetic gabapentinoids, exemplified by gapapentin and pregabalin, are in extensive clinical use for indications including epilepsy, neuropathic pain, anxiety, and alcohol withdrawal. Their mechanisms of action are incompletely understood, but are thought to involve inhibition of α(2)δ subunit–cont...
Enregistré dans:
| Publié dans: | Mol Pharmacol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The American Society for Pharmacology and Experimental Therapeutics
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6108572/ https://ncbi.nlm.nih.gov/pubmed/30021858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.118.112953 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|